Insightec Reaches 10,000 EMEA Patients With MRgFUS
HAIFA, Israel and FRANKFURT, Germany — September 8, 2026 Insightec announced that more than 10,000 patients across Europe, the...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
HAIFA, Israel and FRANKFURT, Germany — September 8, 2026 Insightec announced that more than 10,000 patients across Europe, the...
ANTWERP, Belgium – November 12, 2025 — Minze Health, a digital health company focused on urinary and bladder conditions,...
